Cetrorelix Acetate Injection shortage
Cetrorelix Acetate Injection is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Oct 3, 2026.
Teva is permanently stopping production of its cetrorelix acetate injection. Other makers — including the brand Cetrotide (cetrorelix acetate) — still list supply, so the medicine remains available from those sources.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Cetrorelix Acetate Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Nov 13, 2025Currently in shortage1 of 1 product affected.
-
Nov 13, 2025First reported to the FDA1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Teva Pharmaceuticals USA, Inc. 📞 800-545-8800 1 NDC click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Cetrorelix Acetate, Injection, Kit (NDC 0480-5795-08) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Cetrorelix Acetate Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Cetrorelix Acetate Injection? options further down this page.
Why is Cetrorelix Acetate Injection in shortage?
Teva Pharmaceuticals has reported to the FDA that they are permanently stopping the manufacture of their Cetrorelix Acetate Injection Kit (the kit packaged under their label). This isn't a temporary hold-up at the factory or a supply hiccup — it's a full discontinuation of that specific product from Teva.
The FDA data doesn't include a specific reason why Teva made this decision — they simply reported that manufacturing of this product is being discontinued. It's worth knowing that this report covers only Teva's version of this product, so it reflects what's happening with their particular kit, not necessarily every version of cetrorelix acetate out there.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Cetrorelix Acetate Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Cetrorelix Acetate Injection?
Cetrorelix Acetate Injection is currently on the FDA shortage list. I want to walk you through what this means so you can plan your next step calmly.
The report on file comes from one manufacturer, Teva Pharmaceuticals USA, and it covers the injection kit (NDC 0480-5795-08). Teva has marked this product as to be discontinued because they are stopping production of the drug. That means this supply problem may be permanent for the Teva product. Importantly, this report reflects only Teva — it does not mean the medicine is gone from every maker. The same medicine is still listed from several other companies.
Here is what I suggest, in order:
- Do not stop, skip, or change your dose on your own.
- Ask your pharmacy to check whether they can source the same medicine from another maker. The same-ingredient kit is listed from EMD Serono (Cetrotide), Apotex, Fresenius Kabi, and Meitheal — though these may not be in your local stock right away.
- If your pharmacy cannot find it, talk with your prescriber or pharmacist about the best option for you.
For reference, the manufacturer's contact number is listed on this page, though pharmacies usually handle those calls. This is general national information and may not match what your local pharmacy actually has on hand.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Where else can I get Cetrorelix Acetate Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Cetrorelix Acetate Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Cetrotide | Kit · Subcutaneous | EMD Serono, Inc. | 44087-1225-01 | |
| Cetrorelix Acetate | Kit · Subcutaneous | Apotex Corp. | 60505-6270-01 | |
| Cetrorelix Acetate | Kit | FRESENIUS KABI USA, LLC | 65219-0292-77 | |
| Cetrorelix Acetate | Kit · Subcutaneous | Meitheal Pharmaceuticals Inc. | 71288-0558-90 |
Therapeutic equivalents & pricing 7 productsclick to expand
Orange Book–rated equivalents of the affected strengths / sizes, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Cetrotide | EMD | 1 kit | $306.057 | AP | FDA listed |
| Cetrorelix | Teva | 1 kit | — | — | Discontinued |
| Cetrorelix acetate | Apotex | 1 kit | — | AP | FDA listed |
| cetrorelix acetate | FRESENIUS | 1 kit | — | AP | FDA listed |
| Cetrorelix acetate | Qilu | 1 kit | — | AP | FDA listed |
| cetrorelix acetate | Gland | 1 kit | — | AP | FDA listed |
| Cetrorelix Acetate | Meitheal | 1 kit | — | AP | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Cetrorelix Acetate Injection — that fall in the same broad treatment class (lhrh(gnrh) antagonist,pituitary suppressant agents) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Cetrorelix Acetate Injection shortage FAQs
Is Cetrorelix Acetate Injection in shortage?
Which products are affected?
When will Cetrorelix Acetate Injection be available again?
Can I still get Cetrorelix Acetate somewhere?
What should I do if I take Cetrorelix Acetate Injection?
Still have a question about the Cetrorelix Acetate Injection shortage?
Ask a pharmacist about this shortage →View Cetrorelix Acetate Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.